Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Debt / NOTE 2.500% 1/1
-
Market price (% of par)
-
118.3%
-
Total 13F principal
-
$402,246,000
-
Principal change
-
+$12,044,000
-
Total reported market value
-
$476,014,000
-
Number of holders
-
53
-
Value change
-
+$17,441,922
-
Number of buys
-
28
-
Number of sells
-
21
Institutional Holders of MEDICINES CO - NOTE 2.500% 1/1 as of Q2 2016
As of 30 Jun 2016,
MEDICINES CO - NOTE 2.500% 1/1 was held by
53 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$402,246,000
in principal (par value) of the bond.
The largest 10 bondholders included
CNH PARTNERS LLC, CITADEL ADVISORS LLC, UBS ASSET MANAGEMENT AMERICAS INC, Myriad Asset Management Ltd., LAZARD ASSET MANAGEMENT LLC, Luxor Capital Group, LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BASSO CAPITAL MANAGEMENT, L.P., D. E. Shaw & Co., Inc., and WOLVERINE ASSET MANAGEMENT LLC.
This page lists
53
institutional bondholders reporting positions
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.